{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:29:05Z","timestamp":1790976545435,"version":"4.1.0"},"reference-count":36,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,5,1]]},"abstract":"<jats:p>AMD3100, a bicyclam antagonist of the chemokine receptor CXCR4, has been shown to induce rapid mobilization of CD34+ hematopoietic cells in mice, dogs, and humans, offering an alternative to G-CSF mobilization of peripheral-blood hematopoietic stem cells. In this study, AMD3100-mobilized CD34+ cells were phenotypically analyzed, marked with NeoR-containing retroviral vectors, and subsequently transplanted into myeloablated rhesus macaques. We show engraftment of transduced AMD3100-mobilized CD34+ cells with NeoR gene marked myeloid and lymphoid cells up to 32 months after transplantation, demonstrating the ability of AMD3100 to mobilize true long-term repopulating hematopoietic stem cells. More AMD3100-mobilized CD34+ cells are in the G1 phase of the cell cycle and more cells express CXCR4 and VLA-4 compared with G-CSF-mobilized CD34+ cells. In vivo gene marking levels obtained with AMD3100-mobilized CD34+ cells were better than those obtained using CD34+ cells mobilized with G-CSF alone. Overall, these results indicate that AMD3100 mobilizes a population of hematopoietic stem cells with intrinsic characteristics different from those of hematopoietic stem cells mobilized with G-CSF, suggesting fundamental differences in the mechanism of AMD3100-mediated and G-CSF-mediated hematopoietic stem cell mobilization. Thus, AMD3100-mobilized CD34+ cells represent an alternative source of hematopoietic stem cells for clinical stem cell transplantation and genetic manipulation with integrating retroviral vectors.<\/jats:p>","DOI":"10.1182\/blood-2005-09-3592","type":"journal-article","created":{"date-parts":[[2006,1,26]],"date-time":"2006-01-26T21:03:31Z","timestamp":1138309411000},"page":"3772-3778","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":168,"title":["AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates"],"prefix":"10.1182","volume":"107","author":[{"given":"Andre\u0301","family":"Larochelle","sequence":"first","affiliation":[{"name":"From the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD; the National Human Genome Research Institute, National Institutes of Health, Bethesda, MD; AnorMED, Langley, BC, Canada; and the Department of Medicine, University of Wisconsin Comprehensive Care Center, and Wisconsin National Primate Research Center, University of Wisconsin School of Medicine and Public Health, Madison."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Krouse","sequence":"additional","affiliation":[{"name":"From the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD; the National Human Genome Research Institute, National Institutes of Health, Bethesda, MD; AnorMED, Langley, BC, Canada; and the Department of Medicine, University of Wisconsin Comprehensive Care Center, and Wisconsin National Primate Research Center, University of Wisconsin School of Medicine and Public Health, Madison."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Metzger","sequence":"additional","affiliation":[{"name":"From the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD; the National Human Genome Research Institute, National Institutes of Health, Bethesda, MD; AnorMED, Langley, BC, Canada; and the Department of Medicine, University of Wisconsin Comprehensive Care Center, and Wisconsin National Primate Research Center, University of Wisconsin School of Medicine and Public Health, Madison."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Orlic","sequence":"additional","affiliation":[{"name":"From the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD; the National Human Genome Research Institute, National Institutes of Health, Bethesda, MD; AnorMED, Langley, BC, Canada; and the Department of Medicine, University of Wisconsin Comprehensive Care Center, and Wisconsin National Primate Research Center, University of Wisconsin School of Medicine and Public Health, Madison."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Donahue","sequence":"additional","affiliation":[{"name":"From the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD; the National Human Genome Research Institute, National Institutes of Health, Bethesda, MD; AnorMED, Langley, BC, Canada; and the Department of Medicine, University of Wisconsin Comprehensive Care Center, and Wisconsin National Primate Research Center, University of Wisconsin School of Medicine and Public Health, Madison."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Fricker","sequence":"additional","affiliation":[{"name":"From the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD; the National Human Genome Research Institute, National Institutes of Health, Bethesda, MD; AnorMED, Langley, BC, Canada; and the Department of Medicine, University of Wisconsin Comprehensive Care Center, and Wisconsin National Primate Research Center, University of Wisconsin School of Medicine and Public Health, Madison."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Bridger","sequence":"additional","affiliation":[{"name":"From the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD; the National Human Genome Research Institute, National Institutes of Health, Bethesda, MD; AnorMED, Langley, BC, Canada; and the Department of Medicine, University of Wisconsin Comprehensive Care Center, and Wisconsin National Primate Research Center, University of Wisconsin School of Medicine and Public Health, Madison."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia E.","family":"Dunbar","sequence":"additional","affiliation":[{"name":"From the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD; the National Human Genome Research Institute, National Institutes of Health, Bethesda, MD; AnorMED, Langley, BC, Canada; and the Department of Medicine, University of Wisconsin Comprehensive Care Center, and Wisconsin National Primate Research Center, University of Wisconsin School of Medicine and Public Health, Madison."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiman","family":"Hematti","sequence":"additional","affiliation":[{"name":"From the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD; the National Human Genome Research Institute, National Institutes of Health, Bethesda, MD; AnorMED, Langley, BC, Canada; and the Department of Medicine, University of Wisconsin Comprehensive Care Center, and Wisconsin National Primate Research Center, University of Wisconsin School of Medicine and Public Health, Madison."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111823345492600_REF1","doi-asserted-by":"crossref","unstructured":"To LB, Haylock DN, Simmons PJ, Juttner CA. The biology and clinical uses of blood stem cells. Blood. 1997;89: 2233-2258.","DOI":"10.1182\/blood.V89.7.2233"},{"key":"2019111823345492600_REF2","doi-asserted-by":"crossref","unstructured":"Abboud M, Laver J, Blau CA. Granulocytosis causing sickle-cell crisis. Lancet. 1998;351: 959.","DOI":"10.1016\/S0140-6736(05)60614-9"},{"key":"2019111823345492600_","doi-asserted-by":"crossref","unstructured":"Adler BK, Seizman DE, Carabasi MH, et al. Fatal sickle cell crisis after granulocyte colony-stimulating factor administration. Blood. 2001;97: 3313-3314.","DOI":"10.1182\/blood.V97.10.3313"},{"key":"2019111823345492600_REF4","doi-asserted-by":"crossref","unstructured":"Grigg AP. Granulocyte colony-stimulating factor-induced sickle cell crisis and multiorgan dysfunction in a patient with compound heterozygous sickle cell\/beta+ thalassemia. Blood. 2001;97: 3998-3999.","DOI":"10.1182\/blood.V97.12.3998"},{"key":"2019111823345492600_REF5","doi-asserted-by":"crossref","unstructured":"Lapidot T, Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol. 2002;30: 973-981.","DOI":"10.1016\/S0301-472X(02)00883-4"},{"key":"2019111823345492600_REF6","doi-asserted-by":"crossref","unstructured":"Gerlach LO, Skerlj RT, Bridger GJ, Schwartz TW. Molecular interactions of cyclam and bicyclam nonpeptide antagonists with the CXCR4 chemokine receptor. J Biol Chem. 2001;276: 14153-14160.","DOI":"10.1074\/jbc.M010429200"},{"key":"2019111823345492600_REF7","doi-asserted-by":"crossref","unstructured":"Hatse S, Princen K, Bridger G, De Clercq E, Schols D. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett. 2002;527: 255-262.","DOI":"10.1016\/S0014-5793(02)03143-5"},{"key":"2019111823345492600_REF8","doi-asserted-by":"crossref","unstructured":"Hendrix CW, Flexner C, MacFarland RT, et al. Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob Agents Chemother. 2000;44: 1667-1673.","DOI":"10.1128\/AAC.44.6.1667-1673.2000"},{"key":"2019111823345492600_REF9","doi-asserted-by":"crossref","unstructured":"Broxmeyer HE, Orschell CM, Clapp DW, et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med. 2005;201: 1307-1318.","DOI":"10.1084\/jem.20041385"},{"key":"2019111823345492600_REF10","doi-asserted-by":"crossref","unstructured":"Liles WC, Broxmeyer HE, Rodger E, et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood. 2003;102: 2728-2730.","DOI":"10.1182\/blood-2003-02-0663"},{"key":"2019111823345492600_REF11","doi-asserted-by":"crossref","unstructured":"Liles WC, Rodger E, Broxmeyer HE, et al. Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist. Transfusion. 2005;45: 295-300.","DOI":"10.1111\/j.1537-2995.2005.04222.x"},{"key":"2019111823345492600_REF12","doi-asserted-by":"crossref","unstructured":"Devine SM, Flomenberg N, Vesole DH, et al. Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma. J Clin Oncol. 2004;22: 1095-1102.","DOI":"10.1200\/JCO.2004.07.131"},{"key":"2019111823345492600_REF13","doi-asserted-by":"crossref","unstructured":"Flomenberg N, Devine SM, DiPersio JF, et al. The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood. 2005;106: 1867-1874.","DOI":"10.1182\/blood-2005-02-0468"},{"key":"2019111823345492600_REF14","doi-asserted-by":"crossref","unstructured":"Capel B, Hawley R, Covarrubias L, Hawley T, Mintz B. Clonal contributions of small numbers of retrovirally marked hematopoietic stem cells engrafted in unirradiated neonatal W\/Wv mice. Proc Natl Acad Sci U S A. 1989;86: 4564-4568.","DOI":"10.1073\/pnas.86.12.4564"},{"key":"2019111823345492600_","doi-asserted-by":"crossref","unstructured":"Dick JE, Magli MC, Huszar D, Phillips RA, Berstein A. Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of w\/wv mice. Cell. 1985;42: 71-79.","DOI":"10.1016\/S0092-8674(85)80102-1"},{"key":"2019111823345492600_","doi-asserted-by":"crossref","unstructured":"Guenechea G, Gan OI, Dorrell C, Dick JE. Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat Immunol. 2001;2: 75-82.","DOI":"10.1038\/83199"},{"key":"2019111823345492600_","doi-asserted-by":"crossref","unstructured":"Jordan CT, Lemischka IR. Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Dev. 1990;4: 220-232.","DOI":"10.1101\/gad.4.2.220"},{"key":"2019111823345492600_","doi-asserted-by":"crossref","unstructured":"Keller G, Paige C, Gilboa E, Wagner EF. Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors. Nature. 1985;318: 149-154.","DOI":"10.1038\/318149a0"},{"key":"2019111823345492600_","doi-asserted-by":"crossref","unstructured":"Kim HJ, Tisdale JF, Wu T, et al. Many multipotential gene-marked progenitor or stem cell clones contribute to hematopoiesis in non-human primates. Blood. 2000;96: 1-8.","DOI":"10.1182\/blood.V96.1.1"},{"key":"2019111823345492600_REF20","doi-asserted-by":"crossref","unstructured":"Lemischka IR, Raulet DH, Mulligan RC. Developmental potential and dynamic behavior of hematopoietic stem cells. Cell. 1986;45: 917-927.","DOI":"10.1016\/0092-8674(86)90566-0"},{"key":"2019111823345492600_REF21","doi-asserted-by":"crossref","unstructured":"Schmidt M, Zickler P, Hoffmann G, et al. Polyclonal long-term repopulating stem cell clones in a primate model. Blood. 2002;100: 2737-2743.","DOI":"10.1182\/blood-2002-02-0407"},{"key":"2019111823345492600_REF22","doi-asserted-by":"crossref","unstructured":"Donahue RE, Dunbar CE. An update on the use of non-human primate models for preclinical testing of gene therapy approaches targeting hematopoietic cells. Hum Gene Ther. 2001;12: 607-617.","DOI":"10.1089\/104303401300057289"},{"key":"2019111823345492600_REF23","doi-asserted-by":"crossref","unstructured":"Shi P, Hematti P, von Kalle C, Dunbar C. Genetic marking as an approach to studying in vivo hematopoiesis: progress in the non-human primate model. Oncogene. 2002;21: 3274-3283.","DOI":"10.1038\/sj.onc.1205320"},{"key":"2019111823345492600_REF24","doi-asserted-by":"crossref","unstructured":"Donahue RE, Kirby MR, Metzger ME, et al. Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or nonmobilized with granulocyte colony-stimulating factor and\/or stem cell factor. Blood. 1996;87: 1644-1653.","DOI":"10.1182\/blood.V87.4.1644.bloodjournal8741644"},{"key":"2019111823345492600_REF25","unstructured":"Cassel A, Cottler-Fox M, Doren S, Dunbar CE. Retroviral-mediated gene transfer into CD34-enriched human peripheral blood stem cells. Exp Hematol. 1993;21: 585-591."},{"key":"2019111823345492600_REF26","doi-asserted-by":"crossref","unstructured":"Miller AD. Retrovirus packaging cells. Hum Gene Ther. 1990;1: 5-14.","DOI":"10.1089\/hum.1990.1.1-5"},{"key":"2019111823345492600_REF27","doi-asserted-by":"crossref","unstructured":"Wu T, Kim HJ, Sellers SE, et al. Prolonged high-level detection of retrovirally-marked hematopoietic cells in non-human primates after transduction of CD34+ progenitors using clinically feasible methods. Mol Ther. 2000;1: 285-293.","DOI":"10.1006\/mthe.2000.0034"},{"key":"2019111823345492600_REF28","doi-asserted-by":"crossref","unstructured":"Darzynkiewicz Z. Simultaneous analysis of cellular RNA and DNA content. Methods Cell Biol. 1994;41: 401-420.","DOI":"10.1016\/S0091-679X(08)61731-8"},{"key":"2019111823345492600_REF29","doi-asserted-by":"crossref","unstructured":"Roberts AW, Metcalf D. Noncycling state of peripheral blood progenitor cells mobilized by granulocyte colony-stimulating factor and other cytokines. Blood. 1995;86: 1600-1605.","DOI":"10.1182\/blood.V86.4.1600.bloodjournal8641600"},{"key":"2019111823345492600_REF30","doi-asserted-by":"crossref","unstructured":"Kollet O, Spiegel A, Peled A, et al. Rapid and efficient homing of human CD34(+)CD38(-\/low) CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD\/SCID and NOD\/SCID\/B2m(null) mice. Blood. 2001;97: 3283-3291.","DOI":"10.1182\/blood.V97.10.3283"},{"key":"2019111823345492600_REF31","doi-asserted-by":"crossref","unstructured":"Petit I, Szyper-Kravitz M, Nagler A, et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol. 2002;3: 687-694.","DOI":"10.1038\/ni813"},{"key":"2019111823345492600_REF32","doi-asserted-by":"crossref","unstructured":"Levesque JP, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ. Disruption of the CXCR4\/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest. 2003;111: 187-196.","DOI":"10.1172\/JCI15994"},{"key":"2019111823345492600_REF33","doi-asserted-by":"crossref","unstructured":"Levesque JP, Liu F, Simmons PJ, et al. Characterization of hematopoietic progenitor mobilization in protease-deficient mice. Blood. 2004;104: 65-72.","DOI":"10.1182\/blood-2003-05-1589"},{"key":"2019111823345492600_REF34","doi-asserted-by":"crossref","unstructured":"Hematti P, Sellers SE, Agricola BA, et al. Retroviral transduction efficiency of G-CSF+SCF-mobilized peripheral blood CD34+ cells is superior to G-CSF or G-CSF+Flt3-L-mobilized cells in nonhuman primates. Blood. 2003;101: 2199-2205.","DOI":"10.1182\/blood-2002-08-2663"},{"key":"2019111823345492600_REF35","doi-asserted-by":"crossref","unstructured":"Korin YD, Zack JA. Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J Virol. 1998;72: 3161-3168.","DOI":"10.1128\/JVI.72.4.3161-3168.1998"},{"key":"2019111823345492600_REF36","doi-asserted-by":"crossref","unstructured":"Sutton RE, Reitsma MJ, Uchida N, Brown PO. Transduction of human progenitor hematopoietic stem cells by human immunodeficiency virus type 1-based vectors is cell cycle dependent. J Virol. 1999;73: 3649-3660.","DOI":"10.1128\/JVI.73.5.3649-3660.1999"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/9\/3772\/469848\/zh800906003772.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/9\/3772\/469848\/zh800906003772.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T06:31:20Z","timestamp":1586673080000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/107\/9\/3772\/133469\/AMD3100-mobilizes-hematopoietic-stem-cells-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,1]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,5,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-09-3592","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.9122.466597","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,1]]}}}